Analysts Set HealthEquity, Inc. (NASDAQ:HQY) PT at $111.23

Shares of HealthEquity, Inc. (NASDAQ:HQY) have earned a consensus rating of “Moderate Buy” from the thirteen brokerages that are covering the company, Marketbeat reports. One analyst has rated the stock with a hold rating and twelve have issued a buy rating on the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $113.54.

Several research analysts recently commented on the stock. Bank of America raised their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a report on Wednesday, November 13th. Wells Fargo & Company lifted their price target on HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research report on Wednesday. The Goldman Sachs Group started coverage on HealthEquity in a report on Friday, November 15th. They set a “neutral” rating and a $108.00 price objective on the stock. BTIG Research increased their price target on shares of HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a report on Thursday, November 14th. Finally, Royal Bank of Canada raised their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Tuesday, December 10th.

HealthEquity Stock Performance

Shares of HQY stock opened at $105.61 on Monday. HealthEquity has a 52 week low of $65.01 and a 52 week high of $115.59. The firm’s 50-day simple moving average is $104.59 and its two-hundred day simple moving average is $92.98. The firm has a market cap of $9.15 billion, a price-to-earnings ratio of 96.89, a P/E/G ratio of 1.60 and a beta of 0.55. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20.

HealthEquity (NASDAQ:HQY) last released its earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period in the previous year, the company earned $0.40 earnings per share. As a group, equities analysts forecast that HealthEquity will post 2.32 earnings per share for the current year.

Insider Activity

In other news, Director Stuart B. Parker sold 25,000 shares of the firm’s stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the transaction, the director now directly owns 19,061 shares of the company’s stock, valued at approximately $1,843,579.92. This trade represents a 56.74 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $101.56, for a total value of $837,870.00. Following the completion of the sale, the director now directly owns 66,469 shares of the company’s stock, valued at approximately $6,750,591.64. This trade represents a 11.04 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 39,000 shares of company stock worth $3,895,788. 2.20% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the company. Arcadia Investment Management Corp MI bought a new position in shares of HealthEquity during the fourth quarter valued at about $26,000. Transce3nd LLC purchased a new position in shares of HealthEquity during the fourth quarter valued at approximately $29,000. Smartleaf Asset Management LLC raised its holdings in shares of HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after acquiring an additional 98 shares in the last quarter. UMB Bank n.a. lifted its stake in HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after acquiring an additional 164 shares during the period. Finally, Skandinaviska Enskilda Banken AB publ lifted its stake in HealthEquity by 1,934.8% in the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company’s stock worth $45,000 after acquiring an additional 445 shares during the period. 99.55% of the stock is owned by hedge funds and other institutional investors.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.